http://www.medicalnewstoday.com/articles/129828.php
--Frank
Phase-III Laquinimod trial completed patient enrollment
Phase-III Laquinimod trial completed patient enrollment
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2033 Views
-
Last post by NHE
-
- 0 Replies
- 10633 Views
-
Last post by NHE
-
- 0 Replies
- 1102 Views
-
Last post by frodo
-
- 0 Replies
- 1455 Views
-
Last post by NHE
-
- 2 Replies
- 3854 Views
-
Last post by DIM
-
- 1 Replies
- 2700 Views
-
Last post by Tif
-
- 0 Replies
- 2191 Views
-
Last post by NHE
-
- 0 Replies
- 2171 Views
-
Last post by NHE
-
- 0 Replies
- 10252 Views
-
Last post by NHE